PATRICK WALKER: Open Payments
NPI 1780768630 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 47 payments from 15 companies in 2025. Trend: 2023 $1,097 · 2024 $896 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Astellas Pharma US Inc | 3 | $62 |
| ABBVIE INC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Amgen Inc. | 3 | $50 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| Dexcom, Inc. | 1 | $23 |
Products named: CAPLYTA, Kerendia, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Veozah, OTEZLA, INSPIRE.
Industry payments across LA — which companies pay providers there.
